SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.40+1.8%9:44 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (4966)12/2/1997 4:03:00 PM
From: aknahow  Read Replies (1) of 17367
 
Opa Lapril,

How does The Lancet or any similar journal work? Allan Duncan not only responded to Giroirs previous article but also to a similar trial using Protein C which was described in the very same copy in which duncan's letter appeared.

Is it possible that having received his response on the first article he was asked to opine on the yet to appear article also? Or was he sent an advance copy of the second article prior to publication because
his opinion is widely sought? Just interested in understanding how things work.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext